Neurological soft signs in schizophrenic patients with obsessive-compulsive disorder

Psychiatry and Clinical Neurosciences

Volumn 58, Issue 3, 2004, Pages 274-279

  Sevincok, Levent ^a,b   Akoglu, Aybars ^a   Topaloglu, Beyza ^a   Aslantas, Hulya ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b University Tip Fak Psikiyatri AD   (Turkey)

Author keywords

Neurological soft signs; Obsessive compulsive disorder; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROLOGIC DISEASE; NEUROLOGICAL SOFT SIGN; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; AGING; EDUCATION; FEMALE; HUMANS; MALE; MUSCULOSKELETAL EQUILIBRIUM; NERVOUS SYSTEM DISEASES; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 3042822162     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2004.01231.x     Document Type: Article

References (41)

1. Gupta S, Andreasen NC, Arndt S et al. Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and in normal comparison subjects. Am. J. Psychiatry 1995; 152: 191-196.
2. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am. J. Psychiatry 1999; 156: 1349-1357.
3. Heinrichs DW, Buchanan RW. The significance and significance of neurological signs in schizophrenia. Am. J. Psychiatry 1988; 145: 11-18.
4. Wong AHC, Voruganti LNP, Heslegrave Avad AG. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr. Res. 1997; 23: 139-146.
5. Schroder J, Niethammer R, Geider F et al. Neurological soft signs in schizophrenia. Schizophr. Res. 1992; 6: 25-30.
6. Rossi A, De Cataldo S, Di Michele V et al. Neurological soft signs in schizophrenia. Br. J. Psychiatry 1990; 157: 735-739.
7. McNeil TF, Harty B, Blennow G, Cantor-Grae E. Neuromotor deviation in offspring of psychotic mothers: a selective developmental deficiency in two groups of children at heightened psychiatric risk? J. Psychiatr. Res. 1993; 27: 39-54.
8. Erlenmeyer-Kimling X, Golden R, Cornblatt B. A taxometric analysis of cognitive and neuromotor variables in children at risk for schizophrenia. J. Abnorm. Psychol 1989; 98: 203-208.
9. Marcus J, Hans SL, Lewow E, Wilkinson L, Burack CM. Neurological findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr. Bull. 1985; 11: 85-100.
10. King DJ, Wilson A, Cooper SJ, Waddington JL. The clinical correlates of neurological soft signs in chronic schizophrenia. Br. J. Psychiatry 1991; 158: 770-775.
11. Bolton D, Gibb W, Lees A et al. Neurological soft signs in obsessive compulsive disorder: standartised assessment and comparison with schizophrenia. Behav. Neurol. 1998; 11: 197-204.
12. Zohar I, Kaplan Z, Benjamin J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J. Clin. Psychiatry 1993; 54: 385-388.
13. Berman I, Kalinowski A, Berman S, Lengua J, Green A. Obsessions and compulsions in chronic schizophrenia. Compr. Psychiatry 1995; 36: 6-10.
14. Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AJ. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J. Nerv. Ment. Dis. 1998; 186: 150-156.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 1994.
16. Goodman WK, Price LH, Rasmussen SA et al. The Yale-Brown obsessive compulsive scale. Development, use and reliability. Arch. Gen. Psychiatry 1989; 46: 1006-1011.
17. Barnes TRE. A rating scale for drug-induced akathisia. Br. J. Psychiatry 1989; 154: 672-676.
18. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised edn. US Department of Health, Education and Welfare, Washington, DC.
19. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. Suppl. 1970; 212: 11-19.
20. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City, IA, 1983.
21. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City, IA, 1984.
22. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989; 27: 335-350.
23. Cuesta MJ, Peralta V, Zarzuela A, Calvo R, Garcia M, Serrano F. Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophr. Res. 2002; 58: 263-271.
24. Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J. Prevalance of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J. Neuropsychiatry Clin. Neurosci. 2000; 12: 16-24.
25. Tibbo P, Kroetsch M, Warneke CL. Obsessive-compulsive disorder in schizophrenia. J. Psychiatr. Res. 2000; 34: 139-146.
26. Kolakowska T, Williams AO, Jambor K, Ardern M. Schizophrenia with good and poor outcome. III. Neurological soft signs and cognitive impairment and their clinical significance. Br. J. Psychiatry 1985; 146: 348-357.
27. Lawrie SM, Byrne M, Miller P et al. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br. J. Psychiatry 2001; 178: 524-530.
28. Browne S, Clarke M, Gervin M et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychol. Med. 2000; 30: 1433-1441.
29. Allen L, Tejera C. Treatment of clozapine induced obsessive-compulsive symptoms with sertraline. Am. J. Psychiatry 1994; 151: 1096-1097.
30. Poyurovski M, Hermesh H, Weisman A. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clin. Neuropharmacol. 1996; 19: 305-313.
31. Merriam AE, Kay SR, Opler LA, Kushner SF, Van Praag HM. Neurological signs and positive-negative dimension in schizophrenia. Biol. Psychiatry 1990; 28: 181-192.
32. Yazici AH, Demir B, Yazici KM, Gögüs A. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr. Res. 2002; 58: 241-246.
33. Malla AK, Norman RM, Aguilar O, Cortese L. Relationship between neurological 'soft signs' and syndromes of schizophrenia. Acta Psychiatr. Scand. 1997; 96: 274-280.
34. Poyurovski M, Hramenkov S, Isakov V et al. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res. 2001; 102: 49-57.
35. Chen EY, Kwok CL, Au JW, Chen RY, Lau BS. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr. Scand. 2000; 102: 342-349.
36. Morrison-Stewart SL, Williamson PC, Corning WC, Kutcher SP, Merskey H. Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia. Psychol. Med. 1992; 22: 353-359.
37. Hwang MY, Morgan JE, Losconzcy MF. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J. Neuropsychiatry Clin. Neurosci. 2000; 12: 91-94.
38. Fabish K, Fabish H, Langs G, Wieselmann G, Zapotoczyk HG. Obsessive-compulsive symptoms in schizophrenia. Schizophr. Res. 1997; 24: 17.
39. Lysaker PH, Marks KA, Picone JB, Rollins AL, Fastenau PS, Bond GR. Obsessive and compulsive symptoms in schizophrenia. Clinical and neurocognitive correlates. J. Nerv. Ment. Dis. 2000; 188: 78-83.
40. Poyurovski M, Fuchs C, Weizman A. Obsessive-compulsive disorder in patients with first-episode schizophrenia. Am. J. Psychiatry 1999; 156: 1998-2000.
41. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am. J. Psychiatry 1986; 143: 437-441.